Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
tryptophan + theanine + adenosine 5'-monophosphate is a multi-ingredient dietary supplement formulation designed to promote relaxation, reduce anxiety, and support healthy sleep architecture. The combination leverages the synergistic effects of three key molecules: L-tryptophan, an essential amino acid that serves as the primary metabolic precursor for serotonin and melatonin synthesis; L-theanine, an amino acid found in tea leaves that promotes relaxation by antagonizing glutamate receptors and increasing GABA levels without causing drowsiness; and adenosine 5'-monophosphate (AMP), a nucleotide that supports cellular energy and acts as a precursor to adenosine, a key endogenous sleep-promoting signal. This formulation is primarily marketed as a nutraceutical for individuals experiencing stress-related sleep disturbances or mild anxiety.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on tryptophan + theanine + adenosine 5'-monophosphate.